These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31494053)

  • 1. Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors.
    Li C; Mishra AS; Gil S; Wang M; Georgakopoulou A; Papayannopoulou T; Hawkins RD; Lieber A
    Mol Ther; 2019 Dec; 27(12):2195-2212. PubMed ID: 31494053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model.
    Li C; Wang H; Georgakopoulou A; Gil S; Yannaki E; Lieber A
    Mol Ther; 2021 Feb; 29(2):822-837. PubMed ID: 32949495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.
    Wang H; Lieber A
    J Virol; 2006 Dec; 80(23):11699-709. PubMed ID: 16987973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
    Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A
    Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements.
    Wang H; Georgakopoulou A; Li C; Liu Z; Gil S; Bashyam A; Yannaki E; Anagnostopoulos A; Pande A; Izsvák Z; Papayannopoulou T; Lieber A
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia.
    Wang H; Georgakopoulou A; Psatha N; Li C; Capsali C; Samal HB; Anagnostopoulos A; Ehrhardt A; Izsvák Z; Papayannopoulou T; Yannaki E; Lieber A
    J Clin Invest; 2019 Feb; 129(2):598-615. PubMed ID: 30422819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
    Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
    J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
    Bloomer H; Smith RH; Hakami W; Larochelle A
    Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
    Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
    Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies.
    Li C; Psatha N; Wang H; Singh M; Samal HB; Zhang W; Ehrhardt A; Izsvák Z; Papayannopoulou T; Lieber A
    Mol Ther Methods Clin Dev; 2018 Jun; 9():142-152. PubMed ID: 29766024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4.
    Wang H; Germond A; Li C; Gil S; Kim J; Kiem HP; Lieber A
    Blood Adv; 2022 Aug; 6(15):4360-4372. PubMed ID: 35679480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
    Heister T; Heid I; Ackermann M; Fraefel C
    J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells.
    Wang H; Liu Z; Li C; Gil S; Papayannopoulou T; Doering CB; Lieber A
    Blood Adv; 2019 Oct; 3(19):2883-2894. PubMed ID: 31585952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAd6/35++ - A new helper-dependent adenovirus vector platform for
    Wang H; Georgakopoulou A; Zhang W; Kim J; Gil S; Ehrhardt A; Lieber A
    Mol Ther Methods Clin Dev; 2023 Jun; 29():213-226. PubMed ID: 37081854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.
    Wang H; Shayakhmetov DM; Leege T; Harkey M; Li Q; Papayannopoulou T; Stamatoyannopolous G; Lieber A
    J Virol; 2005 Sep; 79(17):10999-1013. PubMed ID: 16103151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAd5/35
    Li C; Psatha N; Gil S; Wang H; Papayannopoulou T; Lieber A
    Mol Ther Methods Clin Dev; 2018 Jun; 9():390-401. PubMed ID: 30038942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Transgene Silencing of Myeloid-Specific Promoters in the
    Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
    Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe and efficient
    Li C; Wang H; Gil S; Germond A; Fountain C; Baldessari A; Kim J; Liu Z; Georgakopoulou A; Radtke S; Raskó T; Pande A; Chiang C; Chin E; Yannaki E; Izsvák Z; Papayannopoulou T; Kiem HP; Lieber A
    Mol Ther Methods Clin Dev; 2022 Mar; 24():127-141. PubMed ID: 35036470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration.
    Zhang C; Cortez NG; Berns KI
    Hum Gene Ther; 2007 Sep; 18(9):787-97. PubMed ID: 17760515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.